Human Lectins and Their Correspondent Glycans in Cell Biology and Clinical Medicine;Endogene Lectine des Menschen und Ihre Zuckerliganden Zellbiologische und Klinische Bedeutung

Medizinische Klinik

Volumn 98, Issue 12, 2003, Pages 717-738

  Köttgen, Eckart ^a   Reutter, Werner ^a   Tauber, Rudolf ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cell adhesion; Glycobiology; Human lectins; Immunomodulation; Infectious diseases; Inflammation; Oncology

Indexed keywords

CALNEXIN; CALRETICULIN; CARBOHYDRATE; CYTOKINE; GALECTIN; GLYCAN; GLYCOCONJUGATE; GLYCOLIPID; GLYCOPEPTIDE; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; LECTIN; PENTRAXIN; PROTEIN; PROTEOGLYCAN; RECOMBINANT PROTEIN;

APOPTOSIS; ATHEROSCLEROSIS; AUTOIMMUNITY; BLOOD GROUP LEWIS SYSTEM; CANCER INVASION; CELL ADHESION; CELL COMMUNICATION; CELL DIFFERENTIATION; CLINICAL MEDICINE; CLINICAL TRIAL; CYTOLOGY; CYTOLYSIS; EMBRYO DEVELOPMENT; ENDOCYTOSIS; EXOCYTOSIS; FERTILIZATION; GLYCOSYLATION; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOMODULATION; INFECTION; INFLAMMATION; MALIGNANT TRANSFORMATION; METASTASIS; MOLECULAR DYNAMICS; NIDATION; NONHUMAN; ORGANOGENESIS; PHYLOGENY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TARGETING; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; CARBOHYDRATE METABOLISM; CELL ADHESION; CELL COMMUNICATION; CELL TRANSFORMATION, NEOPLASTIC; EMBRYONIC AND FETAL DEVELOPMENT; ENDOCYTOSIS; EXOCYTOSIS; FEMALE; GLYCOCONJUGATES; GLYCOLIPIDS; GLYCOPROTEINS; GLYCOSAMINOGLYCANS; GLYCOSYLATION; HUMANS; IMMUNE SYSTEM DISEASES; INFECTION; INFLAMMATION; LECTINS; MALE; MICE; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; POLYSACCHARIDES; PREGNANCY; PROTEINS; PROTEOGLYCANS; SELECTINS; SIGNAL TRANSDUCTION;

EID: 0347419935     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-003-1318-1     Document Type: Review

References (162)

1. Köttgen E, Gerok W. Pathobiochemische Aspekte der Wechselwirkung zwischen Glykoproteinen und Glykoprotein-Rezeptoren. Med Welt 1979;30: 20-9.
2. Leonidas DD, Elbert BL, Zhou Z, et al. Crystal structure of human Charcot-Leyden crytal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins. Structure 1995;3:1379-93.
3. Stockert RJ, Morell AG, Scheinberg ICH, Mammalian hepatic lectin. Science 1974;186:365-6.
4. Loris R. Principles of structures of animal and plant lectins. Biochim Biophys Acta 2002;1572:198-208.
5. Kilpatrick DC. Animal lectins: a historical introduction an overview. Biochim Biophys Acta 2002; 1572:187-97.
6. Engering A, Geijtenbeek TBH, van Kooyk Y. Immune escape through C-type lectins on dendritic cells. Trends Immunol 2002;23:480-5.
7. McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002;109:707-13.
8. Hebert E. Endogenous lectins as cell surface transducers. Biosci Rep 2000;20:213-37.
9. East L, Isacke CM, The mannose receptor family. Biochim Biophys Acta 2002;1572:364-86.
10. Liu FT. Galectins: a new family of regulators of inflammation. Clin Immunol 2000;97:79-88.
11. Crocker PR. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signaling. Curr Opin Struct Biol 2002;12: 609-15.
12. Dahms NM, Hancock MK. P-type lectins. Biochim Biophys Acta 2002;1572:317-40.
13. Goodman AR, Cardozo T, Abagyan R, et al. Long pentraxins: an emerging group of proteins with diverse functions. Cytokine Growth Factor Rev 1996;7:191-202.
14. Ellgaard L, Helenius A. Quality control in the endoplasmatic reticulum. Nat Rev Mol Cell Biol 2003;4:181-91.
15. Schrag JD, Procopio DO, Cygler M, et al. Lectin control of protein folding and sorting in the secretory pathway. Trends Biochem Sci 2003;28:49-57.
16. Cebo C, Vergoten C, Zanetta JP. Lectin activities of cytokines: functions and putative carbohydrate-recognition domains. Biochim Biophys Acta 2002; 1572:422-34.
17. Lieth CW von der, Bohne-Lang A, Lohmann KK. Datenbanken und Werkzeuge für die Glykobiologie. BIOspektrum 2003;5:635-8.
18. Varki A. Biological role of oligosaccharide - all of the theories are correct. Glycobiology 1993;3:97-130.
19. Sandhoff K, Harzer K, Fürst W. Sphingolipid activator proteins. In: Scriver CR. ed. The metabolic and molecular bases of inherited diseases, vol II, 7th edn. New York: McGraw-Hill, 1995:2427-42.
20. Kundu SK. Glycolipids: structure, synthesis, functions. In: Allen HJ, Kisalius EC, eds. Glycoconjugates. New York-Basel-Hongkong: Dekker. 1992:203-62.
21. Ferguson MAJ, Williams F. Cell surface anchoring of proteins via glycosylphosphatidylinositol structures. Annu Rev Biochem 1988;57:285-320.
22. Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 1985; 54:631-64.
23. Mousa SA, ed. Cell adhesion molecules and matrix proteins: role in health and diseases. Berlin-Heidelberg-New York: Springer, 1998.
24. Varki A, Cummings R, Esko J, et al., eds. Essentials of glycobiology. New York: Cold Spring Harbor Laboratory Press, 1999.
25. Fuster MM, Brown JR, Wang L, et al. A disaccharide precursor of sialyl Lewis C inhibits metastatic potential of tumor cells. Cancer Res 2003;63:2775-81.
26. Brown JR, Fuster MM, Whisenant T, et al. Expression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys. J Biol Chem 2003;278:23352-9.
27. Wells L, Hart GW. O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar. FEBS Lett 2003;546:154-8.
28. Schauer R, Kelm S, Reuter G, et al. Biochemistry and role of sialic acids. In: Rosenberg A, ed. Biology of the sialic acids, New York: Plenum Press, 1995:7-67.
29. Reuter G, Gabius HJ. Sialic acids: structure - analysis - metabolism - occurrence - recognition. Biol Chem Hoppe Seyler 1996;377:325-42.
30. Keppler OT, Horstkorte R, Pawlita M, et al. Biochemical engineering of the N-acyl side chain of sialic acid: biological implications. Glycobiology 2001; 11:11R-8R.
31. Yamashita K, Hara-Kuge S, Ohkura T. Intracellular lectins associated with N-linked glycoprotein traffic. Biochim Biophys Acta 1999;1473:147-60.
32. Paulsson K, Wang P. Chaperones and folding of MHC class I molecules in the endoplasmic reticulum. Biochim Biophys Acta 2003;1641:1-12.
33. Aridor M, Balch WE. Integration of endoplasmic reticulum signaling in health and disease. Nat Med 1999;5:745-51.
34. Green DR. Overview: apoptotic signaling pathways in the immune system. Immunol Rev 2003;193:5-9.
35. Makin G, Dive C. Recent advances in understanding apoptosis: new therapeutic opportunities in cancer chemotherapy. Trends Molec Med 2003;9:251-255.
36. Mattson MP, Kroemer G. Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. Trends Mol Med 2003;9:196-205.
37. Liu FT, Patterson RJ, Wang JL. Intracellular functions of galectins. Biochim Biophys Acta 2002; 1572:263-73.
38. Yang RY, Liu FT. Galectins in cell growth and apoptosis. Cell Mol Life Sci 2003;60:267-76.
39. Youakim A, Hathway HJ, Miller DJ, et al. Overexpressing sperm surface β1,4 galactosyltransferase in transgenic mice affects multiple aspects of sperm-egg interactions. J Cell Biol 1994;126:1573-83.
40. Oehninger S. Molecular basis of human sperm-zona pellucida interaction. Cells Tissues Organs 2001; 168:58-64.
41. Fenderson BA, Eddy EM, Hakomori S-I. Glycoconjugate expression during embryogenesis and its biological significance. BioEssays 1990;12:173-9.
42. Fenderson BA, Zehavi U, Hakomori S. A multivalent lacto-N-fucopentaose III-lysyllysine conjugate decompacts preimplantation mouse embryos, while the free oligosaccharide is ineffective. J Exp Med 1984;160:1591-6.
43. Thorpe SJ, Bellairs R, Feizi T. Developmental patterning of carbohydrate antigens during early embryogenesis of the chick: expression of antigens of the poly-N-acetylactosamine series. Development 1988;102:193-210.
44. Genbacev OD, Prakobphol A, Foulk RA, et al. Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface. Science 2003;299:405-8.
45. Bunting M, Harris ES, Mcintyre TM, et al. Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands. Curr Opin Hematol 2002;9:30-5.
46. Campbell RM, Metzler M, Granovsky M, et al. Complex asparagine-linked oligosaccharides in Mgat1-null embryos. Glycobiology 1995;5:535-43.
47. Miyake M, Zenita K, Tanaka O, et al. Stage-specific expression of SSEA 1-related antigens in the developing lung of human embryos and its relation to the distribution of these antigens in lung cancers. Cancer Res 1988;48:7150-8.
48. Fleming S, Brown G. Distribution of fucosylated N-acetyl lactosamine carbohydrate determinants during embryogenesis of the kidney in man. Histochem J 1986;18:61-6.
49. Lackie PM, Zuber C, Roth J. Polysialic acid and N-CAM localization in embryonic rat kidney: mesenchymal and epithelial elements show different patterns of expression. Development 1990; 110:933-47.
50. Voshol H, van Zuylen CWEM, Orberger G, et al. Structure of the HNK-1 carbohydrate epitope on bovine peripheral myelin glycoprotein PO. J Biol Chem 1996;271:22957-60.
51. Nagase T, Shinioda Y, Sanai Y, et al. Differential expression of two glycosyltransferases synthesizing HNK-1 carbohydrate epitope in the sublineages of the rat myogenic progenitors. Mech Dev; 98:145-9.
52. Bloor DJ, Metcalfe AD, Rutherford A, et al. Expression of cell adhesion molecules during human preimplantation embryo development. Mol Hum Reprod 2002;8:237-45.
53. Milstone DS, O'Donnell PE, Stavrakis G, et al. E-selectin expression and stimulation by inflammatory mediators are developmentally regulated during embryogenesis. Lab Invest 2000;80:943-54.
54. Leshko-Lindsay LA, Corces VG. The role of selectines in Drosophila eye and bristle development. Development 1997;124:169-80.
55. Song HH, Filmus J. The role of glypicans in mammalian development. Biochim Biophys Acta 2002;1573:241-6.
56. Jessel TM, Hynes MA, Dodd J. Carbohydrates and carbohydrate-binding proteins in the nervous system. Annu Rev Neurosci 1990;13:227-55.
57. Schachner M. Neural recognition molecules and synaptic plasticity. Curr Opin Cell Biol 1997;9: 627-34.
58. Benson D, Schnapp LM, Shapiro L, et al. Making memories stick: cell-adhesion molecules in synaptic plasticity. Trends Cell Biol 2000;10:473-82.
59. Rutishauser U. Polysialic acid and the regulation of cell interactions. Curr Opin Cell Biol 1996;8:6 79-84.
60. Heiland PC, Griffith LS, Lange R, et al. Tyrosine and serine phosphorylation of the neural cell adhesion molecule L1 is implicated in its oligomannosidic glycan dependent association with NCAM and neurite outgrowth. Eur J Cell Biol 1998;75:97-106.
61. Kleene R, Yang H, Kutsche M, et al. The neural recognition molecule L1 is a sialic acid binding lectin for CD24, which induces promotion and inhibition of neurite outgrowth. J Biol Chem 2001;276: 21656-63.
62. Hall H, Carbonetto S, Schachner M. L1/HNK-1 carbohydrate- and beta 1 integrin-dependent neural cell adhesion to laminin-1. J Neurochem 1997;68:544-53.
63. Strekalova T, Wotjak CT, Schachner M. Intrahippocampal administration of an antibody against the HNK-1 carbohydrate impairs memory consolidation in an inhibitory learning task in mice. Mol Cell Neurosci 2001;17:1102-13.
64. 2 integrins in vivo. Proc Natl Acad Sci U S A 1991;88:7538-42.
65. Gallatin WM, Weisman IL, Butcher EC. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 1983;304:30-4.
66. Frenette PS, Subbarao S, Mazo IB, et al. Endothelial selectins and vascular adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc Natl Acad Sci U S A 1998;195:14423-8.
67. Vestweber D, Blanks JE. Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 1999;79:181-213.
68. Warnock RA, Askari S, Butcher EC, et al. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J Exp Med 1998;187:205-16.
69. Gohlke M, Mach U, Nuck K, et al. H (0) blood group determinant is present on soluble human L-selectin expressed in BHK cells. FEBS Lett 1999; 450:111-6.
70. Gohlke M, Mach U, Nuck R, et al. Carbohydrate structures of soluble human L-selectin recombinantly expressed in baby hamster kidney cells. Biotechnol Appl Biochem 2000;32:41-51.
71. Fieger C, Emig-Vollmer S, Petri T, et al. Adhesive properties of recombinant soluble L-selectin are modulated by its glycosylation. Biochim Biophys Acta 2000;1524:75-85.
72. Zöllner O, Lenter MC, Blanks JE, et al. L-selectin from human but not from mouse neutrophils binds directly to E-selectin. J Cell Biol 1997;136:707-16.
73. Varki A. Selectin ligands: will the real ones please stand up. J Clin Invest 1997;99:1-5.
74. Fuhlbrigge RC, Kieffer JD, Amerding A, et al. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 1997;389:978-81.
75. Steegmaier M, Levinovitz A, Isenman I, et al. The E-selectin ligand is a variant of a receptor for the fibroblast growth factor. Nature 1995;373:615-20.
76. Diacovo TG, Roth SJ, Morita TC, et al. Interactions of human α/β and γ/δ T lymphocyte subsets in shear flow with E-selectin and P-selectin. J Exp Med 1996;183:1193-203.
77. Picker LJ, Warnock RA, Burns AR, et al. The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selectin ELAM-1 and GMP-140. Cell 1991;66:921-33.
78. Rosen SD. Endothelial ligands for L-selectin: from lymphocyte recirculation to allograft rejection. Am J Pathol 1999;155:1013-20.
79. Fieger CB, Sassetti CM, Rosen SD. Endoglycan, a member of the CD34 family, functions as an L-selectin ligand through modification with tyrosine sulfation and sialyl Lewis x. J Biol Chem 2003; 278:27390-8.
80. Ramos CL, Smith MJ, Snapp KR, et al. Functional characterization of L-selectin ligands on human neutrophils and leukemia cell lines: evidence for mucinlike ligand activity distinct from P-selectin glycoprotein ligand-1. Blood 1998;91:1067-75.
81. Harms G, Kraft R, Grelle G, et al. Identification of nucleolin as a new L-selectin ligand. Biochem J 2001;360:531-8.
82. Eriksson EE, Xie X, Werr J, et al. Importance of primary capture and L-selectin dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. J Exp Med 2001; 194:205-17.
83. McEver RP, Cummings RD. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 1997;100:485-92.
84. Wilkins PP, Moore KL, McEver RP, et al. Tyrosine sulfatation of P-selectin glycoprotein ligand-1 is required for high affinity binding to P-selectin. J Biol Chem 1995;270:22677-80.
85. Dwir O, Kansas GS, Alon R. An activated L-selectin mutant with conserved equilibrium binding properties but enhanced ligand recognition under shear flow. J Biol Chem 2000;275:18682-91.
86. X and PSGL-1. Cell 2000;103: 467-79.
87. X tetrasaccharide, free in solution and bound to E-, P- and L-selectin. J Am Chem Soc 1997;119:1727-36.
88. Croce K, Freedman SJ, Furie BC, et al. Interaction between soluble P-selectin and P-selectin glycoprotein ligand 1: equilibrium binding analysis. Biochemistry 1998;37:16472-80.
89. Aplin AE, Howe A, Alahari SK, et al. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev 1998;50:197-262.
90. Crockett-Torabi E. Selectins and mechanisms of signal transduction. J Leukoc Biol 1998;63:1-14.
91. Brenner B, Weinmann S, Grassme H, et al. L-selectin activates JNK via src-like tyrosine kinases and the small G-protein Rac. Immunology 1997;92 :214-9.
92. Haribabu B, Steeber DA, Ali H, et al. Chemoattractant receptor-induced phosphorylation of L-selectin. J Biol Chem 1997;272:13961-5.
93. Kahn J, Walcheck B, Migaki GI, et al. Calmodulin regulates L-selectin adhesion molecule expression and function through a protease-dependent mechanism. Cell 1998;92:809-18.
94. Brenner B, Kadel S, Birle A, et al. L-selectin tyrosine phosphorylates cbl and induces association of tyrosine-phosphorylated cbl with crkl and grb2. Biochem Biophys Res Commun 2001;282:41-7.
95. Hidari KI, Weyrich AS, Zimmerman GA, et al. Engagement of P-selectin glycoprotein ligand-1 enhances tyrosine phosphorylation and activates mitogen-activated protein kinases in human neutrophils. J Biol Chem 1997;272:28750-6.
96. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiavasc Res 2002;53:31-47.
97. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
98. Briscoe DM, Yeung AC, Schoen EL, et al. Predicitve value of inducible endothelial cell adhesion molecule expression for acute rejection of human cardiac allografts. Transplantation 1995;59:204-11.
99. Ley K. Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res 1996;32:733-42.
100. Jung U, Norman KE, Ramos CL, et al. Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo. J Clin Invest 1998;102:1526-33.
101. Patel KD, Cuvelier SL, Wiehler S. Selectins: critical mediators of leukocyte recruitment. Immunology 2002;14:73-81.
102. Weyrich AS, Ma XL, Lefer DJ, et al. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993;91:2620-9.
103. Hayward R, Campbell B, Shin YK, et al. Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. Cardiovasc Res 1999;41:65-76.
104. Palazzo AJ, Jones SP, Anderson DC, et al. Coronary endothelial P-selectin in pathogenesis of myocardial ischemia-reperfusion injury. Am J Physiol 1998; 5:H1865-72.
105. Herrmann SM, Ricard S, Nicaud V, et al. The P-selectin gene is highly polymorphic: reduced frequency of the pro715 allele carriers in patients with my ocardial infarction. Hum Mol Genet 1998;97: 1277-84.
106. Frijns CJ, Kappelle LJ. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 2002;33:2115-22.
107. Burne-Taney MJ, Rabb H. The role of adhesion molecules and T cells in ischemic renal injury. Curr Opin Nephrol Hypertens 2003;12:85-90.
108. Shan PK. Inflammation, neointimal hyperplasia and restenosis. Circulation 2003;107:2175-7.
109. Berliner JA, Vora DK, Shih PT. Control of leukocyte adhesion and activation in atherogenesis. In: Pearson JD, ed. Vascular adhesion molecules and inflammation. Basel: Birkhäuser, 1999:239-56.
110. Johnson RC, Chapman SM, Dong ZM, et al. Absence of P-selectin delays fatty streak formation in mice. J. Clin Invest 1997;99:1037-43.
111. Dong ZM, Chapman SM, Brown AA, et al. The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 1998;102:145-52.
112. Ramos CL, Huo Y, Jung U, et al. Direct demonstration of P-selectin and VCAM-1-dependent mononuclear rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res 1999;84:1237-44.
113. O'Brien KD, McDonald TO, Chait A, et al. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996;93: 672-82.
114. Fujita T. Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol 2002;2:346-53.
115. O'Shea JJ, Ma A, Lipsky P. Cytokines and autoimmunity. Nat Rev Immunol 2002;2:37-45.
116. Medzhitov R, Janeway C. Innate immunity. N Engl J Med 2000;343:338-44.
117. Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 2001;180:86-99.
118. Kawasaki T. Structure and biology of mannan-binding protein, MBP, an important component of innate immunity. Biochim Biophys Acta 1999; 1473:186-95.
119. Daniels MA, Hogquist KA, Jameson SC. Sweet 'n' sour: the impact of differential glycosylation on T cell responses. Nat Immunol 2002;3:903-10.
120. Soilleux EJ. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related DC-SIGNR): friend or foe? Clin Sci 2003; 104:437-46.
121. Van Kooyk Y, Geijtenbeeg TBH. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 2003;3:697-709.
122. Haataja K, Hallman M. Surfactant proteins as genetic determinants of multifactorial pulmonary diseases. Ann Med 2002;34:324-33.
123. Wu H, Kuzmenko A, Wan S, et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 2003:111:1589-602.
124. Griese M, Wiesener A, Lottspeich F, et al. Limited proteolysis of surfactant protein D causes a loss of its calcium-dependent lectin functions. Biochim Biophys Acta 2003;1638:157-63.
125. Shepherd V. Distinct roles for lung collectins in pulmonary host defence. Am J Respir Cell Mol Biol 2002;26:257-60
126. Lu J, Teh C, Kishore U, et al. Collectins and ficollins: sugar pattern recognition molecules of the mammalian innate immunity. Biochim Biophys Acta 2002;1572:387-400.
127. Amano M, Galvan M, He J, et al. The ST6 Gal I sialyltransferase selectively modifies N-gycans on CD 45 to negatively regulate galectin-1-induced CD45 clustering, phophatase modulation, and T cell death. J Biol Chem 2003;278:7469-575.
128. Rabinovich GA, Rubinstein M, Toscano MA. Role of galectins in inflammatory and immunomodulatory processes. Biochim Biophys Acta 2002;1572:274-85.
129. Sano H, Hsu DK, Apgar JR, et al. Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest 2003;112:389-97.
130. Pritchard NR, Smith KGC. B cell inhibitory receptors and autoimmunity. Immunology 2003;108:263-73.
131. Angata TA. Brinkmann-Van der Linden ECM. I-type lectins. Biochim Biophys Acta 2002;1572:294-316.
132. Schengrund CL. Multivalent saccharides: development of new approaches for inhibiting the effects of glycosphingolipid-binding pathogens. Biochem Pharmacol 2003;65:699-707.
133. Sharon N, Ofek I. Fighting infectious diseases with inhibitors of microbial adhesion to host tissues. Crit Rev Food Sci Nutr 2002;42:267-72.
134. Innocenti M, Thoreson AC, Ferrero RL, et al. Helicobacter pylori-induced activation of human endothelial cells. Infect Immun 2002;70:4581-90.
135. Hynes SO, Teneberg S, Roche N, et al. Glycoconjugate binding of gastric and enterohepatic Helicobacter spp. Infect Immun 2003;71:2976-80.
136. Mahdavi J, Sondén B, Hurtig M, et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002;297:573-8.
137. Byrne MF, Corcoran PA, Atherton JC, et al. Stimulation of adhesion molecule expression by Helicobacter pylori and neutrophil adhesion to human umbilical vein endothelial cells. FEBS Lett 2002; 532:411-4.
138. Scanlin TF, Glick C. Terminal glycosylation in cystic fibrosis. Biochim Biophys Acta 1999;1455:241-53.
139. Gaucher D, Chadee K. Prospect for an Entamoeba histolytica Gal-lectin-based vaccine. Parasite Immunol 2003;25:55-8.
140. Petri WA, Haque R, Mann BJ. The bittersweet interface of parasite and host: lectin-carbohydrate interactions during invasion by the parasite Entamoeba histolytica. Annu Rev Microbiol 2002;56:39-64.
141. Loukas A, Maizels RM, Helminth C-type lectins and host-parasite interactions. Parasitol Today 2000;16: 333-9.
142. Descoteaux A, Turco SJ. Glycoconjugates in Leishmania infectivity. Biochim Biophys Acta 1999; 1455:341-52.
143. Cummings RD, Nyame AK. Shistosome glycocongates. Biochim Biophys Acta 1999;1455:363-74.
144. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 1989;52:257-331.
145. Kobata A. Cancer cells and metastasis. In: Montreuil J, Vliegentbart JFG, Schachter H, eds. Glycoproteins and disease. Amsterdam: Elsevier, 1996: 183-241.
146. Takano R, Muchmore E, Dennis JW. Sialylation and malignant potential in tumour cell glycosylation mutants. Glycobiology 1994;4:665-74.
147. Muramatsu T. Carbohydrate signals in metastasis and prognosis of human carcinomas. Glycobiology 1993;3:294-6.
148. Van den Eijnden, DH, Koenderman AHL, Schiphorst WECM. Biosynthesis of blood group I-active polylactosaminoglycans. J Biol Chem 1988;263:12461-5.
149. Dennis JW, Granovsky M, Warren CE. Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1999;1473:21-34.
150. Demetriou M, Nabi IR, Coppolino M, et al. Reduced contact inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol 1995;130:383-92.
151. Brockhausen I. Pathways O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1999;1473:67-95.
152. Gorelik E, Galili U, Raz A. On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev 2001; 20:245-77.
153. X antigen in liver metastases of human colorectal carcinoma. Cancer Res 1989;49:6883-8.
154. Mannori G, Crottet P, Cecconi O, et al. Differential colon cancer cell adhesion to E-, P- and L-selectin: role of mucin-type glycoproteins. Cancer Res 1995;55:4425-31.
155. Biancone L, Araki M Araki K, et al. Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med 1996;183:581-7.
156. Ogawa H, Inoue M, Tanizawa O, et al. Altered expression of sialyl-Tn, Lewis antigens and carcinoembryonic antigens between primary and metastatic lesions of uterine cervical cancers. Histochemistry 1992;97:311-7.
157. Danguy A, Camby I, Kiss R. Galectins and cancer. Biochim Biophys Acta 2002;1572:285-93.
158. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
159. Lefer DJ. Pharmacology of selectin inhibitors in ischemia/reperfusions states. Annu Rev Pharmacol Toxicol 2000;40:283-94.
160. Romano SJ, Slee DH. Targeting selectins for the treatment of respiratory diseases. Curr Opin Investig Drugs 2001;2:907-13.
161. Phillips JW, Barringhaus KG, Sanders JM, et al. Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation 2003;107:2244-9.
162. Varki NM, Varki A. Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans. Semin Thromb Hemost 2002;28:53-66.